source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

Evonetix appoints Stephanie Brooking as Head of Product Management

Cambridge, UK-based EVONETIX LTD, a company pioneering an innovative approach to scalable and high-fidelity gene synthesis, has appointed Stephanie Brooking as Head of Product Management. Evonetix aims to utilise its innovative silicon chip approach to deliver a high-throughput solution for…

Evonetix establishes scientific advisory board

EVONETIX LTD, a Cambridge, UK-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, has formed a scientific advisory board (SAB) with the appointment of Professor David Klenerman FMedSci FRS and Professor Andrew Briggs to advise the company…

Avacta appoints Dr Jose Saro as Chief Medical Officer

Avacta Group plc has appointed Dr Jose Saro (pictured left) as Chief Medical Officer to lead the Group’s therapeutic development strategy and drive its in-house programmes into the clinic. Dr Saro brings more than 20 years’ experience in the preclinical,…

Concept Life Sciences forms Scientific Advisory Board

Drug discovery and development specialist and analytical services company Concept Life Sciences has completed the formation of its Scientific Advisory Board (SAB) for the drug discovery and development side of the business. The members are leading experts in a diverse…

Sangamo finalises TxCell acquisition

Sangamo Therapeutics, Inc. has completed its acquisition of TxCell, SA, which has been delisted from the French stock market. “The acquisition of TxCell immediately positions Sangamo as the leader in CAR-Treg development,” said Sandy Macrae, CEO of Sangamo. “By combining…
Subscribe to this RSS feed